0233: Mingyuan Medicare Development Company Limited - Summary | Jitta

Mingyuan Medicare Development Company Limited

HKG:0233

Notice
Stock data is unavailable or the company’s delisted.
Price
HK$0.23
Loss Chance
58.4%
n/aJITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
Sorry, the data is not yet available for this stock.
HISTORICAL JITTA SCORE
Sorry, the data is not yet available for this stock.
Related
Sorry, the data is not yet available for this stock.
Jitta Factors
Sorry, the data is not yet available for this stock.
Jitta Signs
Revenue and EarningEarning loss detected in 2017
Operating MarginInconsistent
Key Stats
Jitta Score
Jitta Line
n/a
100.00%
COMPANY DESCRIPTION
Mingyuan Medicare Development Company Limited provides medicare solutions for detection and prevention of diseases primarily in China. The company operates through Protein Chips, Health Care, Medical Centres Management, Individualised Target Therapy, and Bio-Drugs divisions. It manufactures and distributes protein chips, such as C-12 products, which detect approximately 12 tumor markers and assist in early detection of 10 prevalent cancer tumor types for hospitals, medical centres, and life insurance companies; and human papilloma viruses DNA testing kits for early screening of cervical cancer and related equipment. The company also offers healthcare services for residents; and specialized molecular diagnostic kits for leukemia, lymphoma, and individualized target cancer therapy. In addition, it is involved in the development, production, and commercialization of non-specific nanotechnology immunomodulatory drugs. The company was formerly known as Shanghai Ming Yuan Holdings Limited and changed its name to Mingyuan Medicare Development Company Limited in June 2005. Mingyuan Medicare Development Company Limited was founded in 2000 and is based in Sheung Wan, Hong Kong.